Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 0.0 | 5.0 |
Min SIP Amount | ₹1000 | ₹100 |
Expense Ratio | 2.11 | 1.42 |
NAV | ₹13.72 | ₹1794.47 |
Fund Started | 12 Jun 2023 | 08 Dec 1994 |
Fund Size | ₹1357.04 Cr | ₹65966.82 Cr |
Exit Load | Exit load of 1%, if redeemed within 365 days. | Exit load of 1% if redeemed within 1 year
|
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 11.25% | 12.77% |
3 Year | - | 21.66% |
5 Year | - | 22.12% |
1 Year
3 Year
5 Year
Equity | 96.61% | 87.74% |
Cash | 3.39% | 11.48% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
HDFC Bank Ltd. | 4.98% |
Bajaj Finance Ltd. | 3.96% |
Cholamandalam Investment and Finance Company Ltd. | 3.89% |
Divi's Laboratories Ltd. | 3.43% |
Dixon Technologies (India) Ltd. | 3.31% |
Tata Motors Ltd. | 3.17% |
Premier Energies Ltd. | 3.06% |
Infosys Ltd. | 2.78% |
Cummins India Ltd. | 2.69% |
Zomato Ltd. | 2.61% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 9.40% |
HDFC Bank Ltd. | 9.27% |
Axis Bank Ltd. | 8.37% |
Kotak Mahindra Bank Ltd. | 4.76% |
Maruti Suzuki India Ltd. | 4.67% |
SBI Life Insurance Company Ltd. | 4.39% |
Cipla Ltd. | 4.31% |
Bharti Airtel Ltd. | 3.99% |
HCL Technologies Ltd. | 3.14% |
Piramal Pharma Ltd. | 2.67% |
Name | Mayur Patel | Dhruv Muchhal |
Start Date | 04 Sep 2023 | 14 Sep 2023 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by primarily investing in equity and equity related securities across the entire market capitalization range and investing the remaining portion in debt and money market instruments. | The scheme seeks to generate capital appreciation / income from a portfolio, predominantly invested in equity & equity related instruments. |
Launch Date | 12 Jun 2023 | 08 Dec 1994 |
Description
Launch Date